Search
Close this search box.

Improving treatment & diagnosis of rare diseases

Funding: $4,800,000

Project offers hope for faster diagnosis of rare diseases

Genome Atlantic project offers hope for faster diagnosis of rare diseases

October 2020

New Atlantic Canada-based genomic research, announced for Dalhousie University and IWK Health, Oct. 26, and supported by Genome Atlantic, hopes to cut wait times for anxious families and pare the cost of diagnosing rare diseases in Canadian children.

Dr. Karen Bedard, a Dalhousie molecular geneticist and academic co-leader for the Dalhousie-IWK collaborative venture, predicts “this project will provide a bedrock for future medical advances as genomic medicine becomes an increasingly broadly used tool across all fields of medicine.”

Read More

Improving treatment & diagnosis of rare diseases in Atlantic Canada

May 2022

Q&A with Dr. Victor Martinez, Clinical Genomics Specialist, IWK Health Centre; Assistant Professor, Department of Pathology, Dalhousie University

The Genome Canada-led All for One initiative is advancing precision health across the country, increasing equitable and timely access to accurate, genomics-enabled clinical diagnosis for Canadians with serious genetic diseases.

At the heart of the initiative are six implementation projects located across Canada. We asked Dr. Victor Martinez from the project team in Atlantic Canada about how All for One will have an impact in his region.

Read More

 

Do you have an idea you'd like to discuss?

Return To All Projects

LET'S DISCUSS YOUR IDEA.

WE FOCUS ON CLIENT LED SOLUTIONS.

BRING US AND IDEA AND WE’LL HELP YOU GET IT INTO ACTION.

LET'S DISCUSS YOUR IDEA.

WE FOCUS ON CLIENT LED SOLUTIONS.

BRING US AND IDEA AND WE’LL HELP YOU GET IT INTO ACTION.